I think this is (unfortunately) correct. Prana conducted these trials hoping to attract a large partner to take them through a phase III. Apparently no one is interested. I will reiterate what I said before. There may be something in the data that shareholders do not know about. Likely it was not in the HD data, but rather AD extension. I'm sure the FDA is concerned about off label use. They will take everything into account.
I think this is (unfortunately) correct. Prana conducted these...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $11.18K | 3.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 52064257 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126697935 | 22 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |